Video

The Long Term Impact of Limited Distribution Networks on Specialty Pharmacy

Author(s):

Lauren Santye, Assistant Editor

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses the relationship between limited distribution networks and specialty pharmacy.

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses the relationship between limited distribution networks and specialty pharmacy.

Related Videos
Related Content
Cimerli Offers a New, Interchangeable Biosimilar for Ocular Conditions
May 1st 2025

Cimerli Offers a New, Interchangeable Biosimilar for Ocular Conditions

Melissa Garcia, PharmD Candidate Saro Arakelians, PharmD
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Health insurance, tax concept on blue background
May 1st 2025

Asembia AXS25: Patients Desire Education and Thorough Resources to Better Navigate Health Plans

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
US FDA logo on smartphone -- Image credit: Luciano Luppa | stock.adobe.com
April 30th 2025

FDA Approves Nipocalimab-Aahu to Treat Patients With Generalized Myasthenia Gravis

Gillian McGovern, Associate Editor
A scientist in sterile coverall gown pipetting medium or reagents for cell culture experiment in biological safety cabinet. Doing biological research in clean environmental.
April 30th 2025

Asembia AXS25: Cell and Gene Therapies Enter New Phase of Growth in Specialty Pharmacy

Luke Halpern, Assistant Editor